Length of stay in long-term care facilities: a comparison of residents in six European countries. Results of the PACE cross-sectional study.


Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
08 03 2020
Historique:
entrez: 11 3 2020
pubmed: 11 3 2020
medline: 7 2 2021
Statut: epublish

Résumé

This paper aims to investigate resident, facility and country characteristics associated with length of stay in long-term care facilities (LTCFs) across six European countries. Data from a cross-sectional study of deceased residents, conducted in LTCFs in Belgium, England, Finland, Italy, the Netherlands and Poland. All residents aged 65 years and older at admission who died in a 3-month period residing in a proportional random sample of LTCFs were included. The primary outcome was length of stay in days, calculated from date of admission and date of death. Resident, facility and country characteristics were included in a proportional hazards model. The proportion of deaths within 1 year of admission was 42% (range 32%-63%). Older age at admission (HR 1.04, 95% CI 1.03 to 1.06), being married/in a civil partnership at time of death (HR 1.47, 95% CI 1.13 to 1.89), having cancer at time of death (HR 1.60, 95% CI 1.22 to 2.10) and admission from a hospital (HR 1.84, 95% CI 1.43 to 2.37) or another LTCF (HR 1.81, 95% CI 1.37 to 2.40) were associated with shorter lengths of stay across all countries. Being female (HR 0.72, 95% CI 0.57 to 0.90) was associated with longer lengths of stay. Length of stay varied significantly between countries. Factors prior to LTCF admission, in particular the availability of resources that allow an older adult to remain living in the community, appear to influence length of stay. Further research is needed to explore the availability of long-term care in the community prior to admission and its influence on the trajectories of LTCF residents in Europe.

Identifiants

pubmed: 32152166
pii: bmjopen-2019-033881
doi: 10.1136/bmjopen-2019-033881
pmc: PMC7064078
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e033881

Informations de copyright

© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

Age Ageing. 2015 May;44(3):497-501
pubmed: 25652076
J Gerontol B Psychol Sci Soc Sci. 2016 Jul;71(4):711-23
pubmed: 26577030
Geriatr Gerontol Int. 2015 Feb;15(2):234-6
pubmed: 25619271
BMC Health Serv Res. 2012 Jan 09;12:5
pubmed: 22230771
Age Ageing. 2013 Mar;42(2):209-15
pubmed: 23305759
J Palliat Med. 2014 Feb;17(2):176-82
pubmed: 24438096
Contemp Clin Trials. 2016 Mar;47:139-45
pubmed: 26772624
J Nutr Health Aging. 2009 Oct;13(8):679-83
pubmed: 19657550
J Am Med Dir Assoc. 2016 Jun 1;17(6):566.e1-7
pubmed: 27161314
Palliat Med. 2018 Dec;32(10):1584-1595
pubmed: 30273519
Int J Public Health. 2013 Apr;58(2):257-67
pubmed: 22892713
J Gerontol B Psychol Sci Soc Sci. 2018 Apr 16;73(4):564-572
pubmed: 28977651
BMC Geriatr. 2007 Jun 19;7:13
pubmed: 17578574
J Pain Symptom Manage. 2013 Feb;45(2):223-34
pubmed: 22917717
Syst Rev. 2019 Feb 20;8(1):56
pubmed: 30786917
Am J Hosp Palliat Care. 2018 Mar;35(3):456-463
pubmed: 28610431
Maturitas. 2018 Jan;107:19-25
pubmed: 29169575
J Am Geriatr Soc. 2010 Apr;58(4):751-6
pubmed: 20398157
BMC Palliat Care. 2014 Oct 23;13:48
pubmed: 25927972
Br J Cancer. 2015 Nov 3;113(9):1397-404
pubmed: 26325102
Palliat Med. 2009 Apr;23(3):190-7
pubmed: 19251834
Am J Psychiatry. 1982 Sep;139(9):1136-9
pubmed: 7114305
Age Ageing. 2010 Jan;39(1):31-8
pubmed: 19934075
Scand J Caring Sci. 2016 Dec;30(4):714-720
pubmed: 26842844
Palliat Med. 2018 Feb;32(2):329-336
pubmed: 29017018
J Am Med Dir Assoc. 2015 Feb;16(2):165-71
pubmed: 25544001
Age Ageing. 2014 Jan;43(1):97-103
pubmed: 23864424
Age Ageing. 2009 Nov;38(6):711-7
pubmed: 19752201
Health Policy. 1990 Dec;16(3):199-208
pubmed: 10109801
BMC Fam Pract. 2013 Jun 03;14:73
pubmed: 23731938
BMC Geriatr. 2015 Oct 01;15:114
pubmed: 26429705
Alzheimer Dis Assoc Disord. 1997 Jun;11(2):71-7
pubmed: 9194953
J Gerontol. 1994 Jul;49(4):M174-82
pubmed: 8014392

Auteurs

Danni Collingridge Moore (D)

International Observatory on End of Life Care, Lancaster University Faculty of Health and Medicine, Lancaster, Lancashire, UK d.collingridgemoore@lancaster.ac.uk.

Sheila Payne (S)

International Observatory on End of Life Care, Lancaster University Faculty of Health and Medicine, Lancaster, Lancashire, UK.

Thomas Keegan (T)

International Observatory on End of Life Care, Lancaster University Faculty of Health and Medicine, Lancaster, Lancashire, UK.

Lieve Van den Block (L)

End-of-Life Care Research Group, Vrije Universiteit Brussel & Ghent University, Brussels, Belgium.

Luc Deliens (L)

End-of-Life Care Research Group, Vrije Universiteit Brussel & Ghent University, Brussels, Belgium.

Giovanni Gambassi (G)

Università Cattolica del Sacro Cuoro, Rome, Italy.

Rauha Heikkila (R)

Ageing, Disability and Functioning Unit, National Institute for Health and Welfare, Helsinki, Finland.

Viola Kijowska (V)

Unit for Research on Aging Society, Department of Sociology, Chair of Epidemiology and Preventive Medicine, Faculty of Medicine, Jagiellonian University Medical College, Krakow, Poland.

H Roeline Pasman (HR)

Department of Public and Occupational Health, Amsterdam Public Health research institute, Expertise center for Palliative Care, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, Netherlands.

Lara Pivodic (L)

End-of-Life Care Research Group, Vrije Universiteit Brussel & Ghent University, Brussels, Belgium.

Katherine Froggatt (K)

International Observatory on End of Life Care, Lancaster University Faculty of Health and Medicine, Lancaster, Lancashire, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH